Octreotide in the treatment of congenital chylothorax

Journal of Paediatrics and Child Health

Volumn 40, Issue 9-10, 2004, Pages 585-588

  Rasiah, S V ^a   Oei, J ^a,b   Lui, K ^a,b  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Congenital chylothorax; Neonate; Octreotide

Indexed keywords

OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ABDOMINAL DISTENSION; ANAMNESIS; ARTICLE; CASE REPORT; CHYLOTHORAX; CLINICAL EXAMINATION; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DIAGNOSTIC APPROACH ROUTE; DIET THERAPY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; INFANT; LABORATORY TEST; LYMPHOCYTOPENIA; NEUTROPENIA; PATENT DUCTUS ARTERIOSUS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT INDICATION; TREATMENT OUTCOME;

CHYLOTHORAX; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL AGENTS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; OCTREOTIDE; TIME FACTORS; TREATMENT OUTCOME;

EID: 6344226356     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00471.x     Document Type: Article

References (32)

1. Smeltzer DM, Sticker GB, Fleming RE. Primary lymphatic dysplasia in children: Chylothorax, chylous ascites, and generalised lymphatic dysplasia. Eur. J. Pediatr. 1986; 45: 286.
2. Levine C. Primary disorders of the lymphatic vessels - a unified concept. J. Pediatric Surg. 1989; 24: 233-40.
3. Hilliard RI, McKendry JB, Phillips MJ. Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics 1990; 86: 988-94.
4. Adiotomre PN, Burns JE, McIntosh N. Hydrops foetalis and chylothorax associated with superior caval vein obstruction and resolution following balloon dilatation. Acta Pediatrics 1994; 83: 983-5.
5. Easa D, Balaraman V, Ash K et al. Congenital Chylothorax and mediastinal neuroblastoma. J. Pediatric Surg. 1991; 26: 96-8.
6. Hesseling PB, Hoffman H. Chylothorax: a review of the literature and report of 3 cases. S. Afr. Med. 1981; 60: 675-8.
7. Van Aerde J, Campbell AN, Smyth JA. Spontaneous chylothorax in newborns. Am. J. Dis. Child 1984; 138: 961-4.
8. Ho NK, Leong NK, Lim SB. Chylothorax in Down's syndrome associated with hydrops fetalis. J. Singapore Paediatric Soc. 1989; 31: 90-2.
9. Harvey JG, Houlsby W, Sherman K et al. Congenital Chylothorax: report of unique case associated with 'H' - type tracheooesophageal fistula. Br. J. Surg. 1979; 66: 485-7.
10. Longaker MT, Laberge JM, Dansereau J et al. Primary fetal hydrothorax: natural history and management. J. Pediatric Surg. 1989; 24: 573-6.
11. Azizkhan RG, Canfield J, Alford BA et al. Pleuroperitoneal shunts in the management of neonatal chylothorax. J. Pediatric Surg. 1983; 18: 842-50.
12. Anderson EA, Hertel J, Pedersen SA et al. Congenital chylothorax: management by ligature of the thoracic duct. Scand. J. Thorac. Cardiovasc. Surg. 1984; 18: 193-4.
13. Al-Tawil K, Ahmed G, Al-Hathal M et al. Congenital chylothorax. Am. J. Perinatol. 2000; 17: 121-6.
14. Wolff AB, Silen ML, Kokoska ER et al. Treatment of refractory chylothorax with externalised pleuroperitoneal shunts in children. Ann. Thorac. Surg. 1999; 68: 1053-7.
15. Takahashi M, Kurokawa Y, Toyama H et al. The successful management of thoracoscopic thoracic duct ligation in a compromised infant with targeted lobar deflation. Anesth. Analg. 2001; 93: 96-7.
16. Buettiker V, Hug MI, Burger R et al. Somatostatin: a new therapeutic option for the treatment of chylothorax. Intens. Care Med. 2001; 27: 1083-6.
17. Rimensberger PC, Muller-Schenker B, Kalangos A et al. Treatment of a persistent postoperative chylothorax with somatostatin. Ann. Thorac. Surg. 1998; 66: 253-4.
18. Pettitt TW, Caspi J, Borne A. Treatment of persistent chylothorax after Noorwood procedure with Somatostatin. Ann. Thorac. Surg. 2002; 73: 977-9.
19. Rosti L, Bini RM, Chessa M, Butera G, Drago M, Carminati M. The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur. J. Pedlatr. 2002; 161: 149-50.
20. Cheung Y, Leung MP, Yip M. Octreotide for treatment of post-operative chylothorax. J. Pediatr. 2001; 139: 157-9.
21. Pratap U, Slavik Z, Ofoe VD, Franklin R. Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann. Thorac. Surg. 2001; 72: 1740-2.
22. Lam JC, Aters S, Tobias JD. Initial experience with Octreotide in the pediatric population. Am. J. Therapeutics 2001; 8: 409-15.
23. Beghetti M, La Scala G, Belli D et al. Etiology and management of pediatric chylothorax. J. Pediatrics 2000; 136: 653-8.
24. Chernick V, Reed MH. Pneumothorax and chylothorax in the neonatal period. J. Pediatrics 1970; 76: 624-32.
25. Dubin PJ, King IN, Gallagher PG. Congenital Chylothorax. Curr. Opin. Pedlatr. 2000; 12: 505-9.
26. Mulvihill S, Pappas TN, Passaro E et al. The use of somatostatin and its analogs in the treatment of surgical disorders. Surgery 1986; 100: 467-75.
27. Siafakas C, Fox VL, Nurko S. Use of octreotide for the treatment of severe gastrointestinal bleeding in children. J. Pediatric Gastroenterol. Nutr. 1998; 26: 356-9.
28. Tauber MT, Harris AG, Rochiccioli P. Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur. J. Pediatr. 1994; 153: 304-10.
29. Lamberts SWJ, van der Lely AJ, de Herder WW, Hofland LJ. Drug therapy: Octrotide. N. Engl. J. Med. 1996; 334: 246-54.
30. Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycaemia of infancy: long-term octreotide treatment without pancreatectomy. J. Pediatrics 1993; 123: 644-50.
31. Davis SN, Granner DK. Insulin, oral hypoglycaemic agents and the pharmacology of the endocrine pancreas. In: AG Gilmand, JG Hardman, LE Limbird, PB Molionaff, RW Ruddon, eds, Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th edn. New York: Pergamon Press, 1996; 1512-3.
32. Nakabayashi H, Sagara H, Usukura N et al. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomised dogs. Diabetes 1981; 30: 440-5.